Schizophrenia Trial, Recruiting (NCT07060742)

Schizophrenia Trial, Recruiting NCT07060742 Sponsor: Tobias Melcher Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT07060742 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with a psychotic disorder
People who are aged 55 years or older
People who are able to sign a consent form agreeing to take part
People who score 20 or higher on a standard memory and thinking test called the MoCA
People who are able to stand on their own, without holding onto anything, for at least 3 minutes (based on self-report)

Who may not be able to join:

People who do not have a sufficient understanding of the German language to follow instructions, play the games, and complete the assessments
People whose movement, thinking, senses, or mental health conditions make it difficult to participate in the exercise games or complete the required tests before and after the program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tobias Melcher, Dr. Dripl.Psych., Universitäre Psychiatrischen Kliniken (UPK) Basel

Phone: +41 61 325 5163

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07060742

Sponsor: Tobias Melcher

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +41 61 325 5163

More information: https://clinicaltrials.gov/study/NCT07060742

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with a psychotic disorder
People who are aged 55 years or older
People who are able to sign a consent form agreeing to take part
People who score 20 or higher on a standard memory and thinking test called the MoCA
People who are able to stand on their own, without holding onto anything, for at least 3 minutes (based on self-report)

Who may not be able to join:

People who do not have a sufficient understanding of the German language to follow instructions, play the games, and complete the assessments
People whose movement, thinking, senses, or mental health conditions make it difficult to participate in the exercise games or complete the required tests before and after the program

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tobias Melcher

Registry

ClinicalTrials.gov

Start date

9 June 2025

Est. completion

15 May 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Feasibility of the exergame-based motor-cognitive training: adherence; Feasibility of the exergame-based motor-cognitive training: attrition; Feasibility of the exergame-based motor-cognitive training: safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov